Newsfeeds - Spark Newswire

5 minute read

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout

Today, 6:17 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28)

ABUS

1 minute read

Cerevel Therapeutics Stock Shoots Higher As Schizophrenia Treatment Tops Placebo On Antipsychotic Activity

By Vandana Singh

Today, 6:17 PM

Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) has announced results from its Phase 1b trial of CVL-231 in adult patients with schizophrenia. CVL-231…

CERE

4 minute read

Cerevel Therapeutics Announces Topline Results For CVL-231 In Phase 1b Clinical Trial In Patients With Schizophrenia; Says Both Doses Demonstrated Clinically Meaningful And Statistically Significant In PANSS Total Score

By Bill Haddad

Today, 6:17 PM

Both doses of CVL-231 demonstrated a clinically meaningful and statistically significant improvement in PANSS Total score at 6 weeks and were overall well-tolerated compared with placebo 30 mg of CVL-231

CERE

10 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 18, 2021

By Benzinga Insights

Today, 6:17 PM

ABMD

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 6:17 PM

ADXN

1 minute read

Morgan Stanley Initiates Coverage On Cerevel Therapeutics Hldg with Overweight Rating, Announces Price Target of $27

By Benzinga Newsdesk

Today, 6:17 PM

Morgan Stanley analyst Matthew Harrison initiates coverage on Cerevel Therapeutics Hldg (NASDAQ:CERE) with a Overweight rating and announces Price Target of $27.

CERE

1 minute read

Cerevel Therapeutics Announces Fast Track Designation Granted By The FDA To CVL-871 For The Treatment Of Dementia-Related Apathy

By Bill Haddad

Today, 6:17 PM

Cerevel Therapeutics (NASDAQ:CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that the U.S. Food and Drug Administration (FDA) has granted

CERE

6 minute read

Uncategorized

Earnings Scheduled For May 17, 2021

By Benzinga Insights

Today, 6:17 PM

Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter.

ACRX

2 minute read

Uncategorized

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

By Shanthi Rexaline

Today, 6:17 PM

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.

ACRX